Ignite Creation Date:
2025-12-25 @ 2:49 AM
Ignite Modification Date:
2025-12-26 @ 1:31 AM
Study NCT ID:
NCT03452033
Status:
COMPLETED
Last Update Posted:
2022-07-12
First Post:
2018-02-26
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
H-1337 Ophthalmic Solution Phase 1/2
Sponsor:
Allysta Pharmaceutical
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-15
Start Date Type:
ACTUAL
Primary Completion Date:
2018-08-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08-15
Completion Date Type:
ACTUAL
First Submit Date:
2018-02-26
First Submit QC Date:
None
Study First Post Date:
2018-03-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-06-21
Results First Submit QC Date:
None
Results First Post Date:
2021-08-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2021-08-02
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-06-23
Last Update Post Date:
2022-07-12
Last Update Post Date Type:
ACTUAL